收藏切换
Advances in drug delivery strategies against Helicobacter pylori
收藏切换
PDF
Xiao-nan CHEN, Ying-ying SUN, Peng-yu LI, Yi-qin RAO, Shi-hui YU, Hai-yan HU*
Acta Pharmaceutica Sinica | 2021, 56(9) : 2495 - 2504
Less
收藏切换
Acta Pharmaceutica Sinica | 2021, 56(9): 2495-2504
Reviews
Advances in drug delivery strategies against Helicobacter pylori
Full
Xiao-nan CHEN, Ying-ying SUN, Peng-yu LI, Yi-qin RAO, Shi-hui YU, Hai-yan HU*
Affiliations
  • School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China
Published: 2021-09-12 doi: 10.16438/j.0513-4870.2021-0471
Outline
收藏切换

Helicobacter pylori (H. pylori) can cause a variety of digestive tract diseases, the serious may develop into gastric cancer. Nowadays, H. pylori infection rate exceeds 50%, and its eradication rate is declining due to the continuous increase of drug resistance, leading to the occurrence of plenty of stubborn infections, which seriously threaten human health. At present, it is difficult to achieve satisfactory curative effect by increasing the types of antibiotics combination or increasing their dose. In this review, the clinical treatments of H. pylori were introduced. Proceed from the characteristics and pathological background of H. pylori infection that makes H. pylori difficult to eradicate, the research advances of drug delivery strategies for improving H. pylori eradication rate were reviewed, such as strategies that could increase drug concentration in stomach (e.g. drug delivery systems with gastric acid-stabilized ability), increase drug concentration in H. pylori colonization sites (e.g. drug delivery systems with gastric retention or H. pylori targeted abilities), overcome H. pylori resistance (metal nanoparticles, anti-biofilm delivery systems), enhance host immune response (vaccine preparation) and so on. Novel drug delivery systems, such as cell membrane coating technology and phage therapy, are comparatively rare in the field of anti-H. pylori, but have broad application prospects. This review would provide reference for the development and application of therapeutic strategies to improve H. pylori eradication rate.

Helicobacter pylori  /  bacterial infection  /  drug resistance  /  eradication  /  drug delivery system
Xiao-nan CHEN, Ying-ying SUN, Peng-yu LI, Yi-qin RAO, Shi-hui YU, Hai-yan HU. Advances in drug delivery strategies against Helicobacter pylori[J]. Acta Pharmaceutica Sinica, 2021 , 56 (9) : 2495 -2504 . DOI: 10.16438/j.0513-4870.2021-0471
Year 2021 volume 56 Issue 9
PDF
177
75
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2021-0471
  • Receive Date:2021-03-31
  • Online Date:2025-12-18
  • Published:2021-09-12
Article Data
Affiliations
History
  • Received:2021-03-31
  • Revised:2021-04-28
Funding
Affiliations
    School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2021-0471
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT